IFNG and cancer: Most important, an efficient reversible negative regulation of IL2 and IFNγ secretion with subsequent impairment of cancer cell killing demonstrated that CAR-T cells can be turned off in case of excessive cytokine release, thereby avoiding potentially adverse effects, which needs to be tested in the future in vivo as well.